RNA regulation and disease
RNA regulation and disease is a research topic within Molecular Biology. Science Explorer counts 28k research works in it since 1950. 19.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the functions and regulation of RNA editing by ADAR deaminases, including its impact on gene regulation, innate immunity, microRNA processing, and the genomic landscape. It covers a wide range of topics such as neurological disorders, cancer, and transcriptome diversity.
- RNA Editing
- ADAR Deaminases
- Gene Regulation
- Innate Immunity
- MicroRNA Processing
- Genomic Landscape
- Neurological Disorders
- Cancer
- Transcriptome Diversity
- Nucleic Acid Sensing
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 5.6k per year above
- Top-10% rate
- 19.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +27% the tick is no change
Which countries lead RNA regulation and disease research?
By volume, China and the United States publish the most (1.2k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.2k works
- 2 United States 1.2k works
- 3 India 263 works
- 4 Japan 227 works
- 5 Germany 191 works
- 6 United Kingdom 169 works
- 7 Italy 163 works
- 8 France 156 works
- 9 South Korea 112 works
- 10 Canada 108 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead RNA regulation and disease research?
By volume in 2022–2025, Sun Yat-sen University publishes the most RNA regulation and disease research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Harvard University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 21 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 3 Harvard UniversityUnited States 19 works
- 4 University of North Carolina at Chapel HillUnited States 18 works
- 5 University of PennsylvaniaUnited States 18 works
- 6 University of California San DiegoUnited States 18 works
- 7 InsermFrance 16 works
- 8 Centre National de la Recherche ScientifiqueFrance 15 works
- 9 Chinese Academy of SciencesChina 14 works
- 10 Central South UniversityChina 14 works
Who are the leading researchers in RNA regulation and disease?
The most-cited researchers publishing on RNA regulation and disease include Mohammad Ali Sahraian, John Hardy and Cornelia M. van Duijn.
- 1 Mohammad Ali Sahraian Iran 4.6k citations
- 2 John Hardy United Kingdom 4k citations
- 3 Cornelia M. van Duijn Netherlands 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is RNA regulation and disease research done?
The largest centres of RNA regulation and disease research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 35.6 works6.1×
Location quotient: how much more of its research is in RNA regulation and disease than the world average.
Where is the best place to study RNA regulation and disease?
Among universities, judged by research, Sun Yat-sen University, Harvard University and University of California San Diego score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Sun Yat-sen UniversityChina | 52.6 | 25.9% | 2.8× | 21 | +130.4% |
| 2 | Harvard UniversityUnited States | 51.1 | 29.9% | 3.2× | 19 | +4.3% |
| 3 | University of California San DiegoUnited States | 50.1 | 24.3% | 4.4× | 18 | +69.5% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 47.6 | 23.5% | 4.4× | 20 | +33.2% |
| 5 | University of PennsylvaniaUnited States | 47.3 | 27.7% | 4.2× | 18 | -0.2% |
| 6 | University of Chinese Academy of SciencesChina | 45.9 | 30.4% | 1.6× | 12 | +537.4% |
| 7 | China Agricultural UniversityChina | 42.5 | 32.8% | 4.5× | 12 | +6.9% |
| 8 | University of California, Los AngelesUnited States | 41.9 | 41.1% | 2.3× | 10 | +44.2% |
| 9 | Southern Medical UniversityChina | 40.1 | 25.2% | 5.6× | 10 | +93.3% |
| 10 | Central South UniversityChina | 39.5 | 21.5% | 1.8× | 14 | +156.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is RNA regulation and disease research growing?
Output in 2018–2022 was 27% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are RNA regulation and disease.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.